May 16, 2016

Welcome to the MLI Intellectual Property Report

This is the inaugural MLI Intellectual Property Report newsletter, a monthly look at all the latest news related to strong protection for great ideas.

To sign up for the MLI IP newsletter, click here.

If you have an article you'd like to submit, please contact [email protected].

Canada's patent 'utiity' regime on trial

The Supreme Court's decision to hear AstraZeneca's appeal and this month's NAFTA hearings on an Eli Lilly complaint shine a light on Canada's unusual legal approach to invalidating patents, writes Adrienne Blanchard on the MLI website.


Dodged bullet or missed opportunity with CHEO settlement?

While there was certainly a win on the costs of genetic testing, the long-term effects of Transgenomic's departure from the Canadian market, and the missed chance to clarify Canada's patent laws, are less clear. Richard C. Owens delves into the issue for the MLI website.


Stop the TPP-IP media pile-on

It has become fashionable to declare the Trans-Pacific Partnership intellectual property provisions a disaster for innovation in Canada, writes Richard C. Owens for the MLI website. But that doesn't make it right.

Other IP news from around the web...

The Macdonald-Laurier Institute: True North In Canadian Public Policy